Trulieve Cannabis Corp. filings document the regulatory record of a British Columbia cannabis issuer operating as a vertically integrated multi-state operator in the U.S. Recent Form 8-K reports cover operating results, Regulation FD presentations, material definitive agreements, executive compensation matters, and board or officer transitions.
Proxy filings describe annual meeting matters, director elections, executive compensation, equity awards, and shareholder governance. Debt-related filings disclose senior secured notes due 2030, indenture terms, subsidiary guarantees, and related capital-structure obligations tied to Trulieve and its restricted subsidiaries.
Trulieve Cannabis Corp. announced it will redeem all of its outstanding 8% Notes due October 6, 2026 for cash. The redemption covers US$368,000,000 principal as of November 4, 2025, at a price of 100% of principal plus accrued and unpaid interest up to, but excluding, the redemption date.
The redemption date is December 5, 2025. Payments and note surrender will occur through Odyssey Trust Company under the existing Indenture. The notes currently trade on the Canadian Securities Exchange as “TRUL.NT.U” and will be delisted in conjunction with the redemption.
Reese Jan, identified as Chief Financial Officer and a director of Trulieve Cannabis Corp. (TRUL), filed an Initial Statement of Beneficial Ownership on Form 3 reporting no ownership of the issuer's common stock as of the 09/08/2025 event date. The filing references an Exhibit 24 Power of Attorney and is signed on behalf of the reporting person by Eric Powers as attorney-in-fact on 09/30/2025.